Eşanu C, Klepsch I, Calciu G, Bucur D, Popescu L G
Endocrinologie. 1983 Apr-Jun;21(2):131-9.
Women with prolactinic pituitary tumor in the fertile period have increased (60-400 ng/ml) blood prolactin values and decreased LH and FSH as compared to healthy women of the same age. Among the mechanisms implied in prolactin hypersecretion in females with prolactinic tumor worth noting are: low receptivity to dopamine, low dopamine production, elevated serotonin and TRH production, stress factors. Suppression of prolactin secretion with bromcriptine induces a rise in LRH and consequently in LH and FSH. A drug treatment is suggested for prolactin hypersecretion in women with prolactinic pituitary tumor, consisting in association of small doses of bromcriptine, L-DOPA, metergolina and thyroxine, and avoidance of stressing circumstances.
处于生育期的催乳素瘤女性患者,其血液中催乳素值升高(60 - 400 ng/ml),与同年龄的健康女性相比,促黄体生成素(LH)和促卵泡生成素(FSH)降低。在催乳素瘤女性患者高催乳素分泌所涉及的机制中,值得注意的有:对多巴胺的低反应性、多巴胺分泌减少、血清素和促甲状腺激素释放激素(TRH)分泌增加、应激因素。用溴隐亭抑制催乳素分泌会导致促性腺激素释放激素(LRH)升高,进而使LH和FSH升高。建议对患有催乳素瘤的女性高催乳素分泌采用药物治疗,包括联合使用小剂量溴隐亭、左旋多巴、麦角苄酯和甲状腺素,并避免应激情况。